All Stocks/Healthcare/HLN

Haleon plc

HLN
HealthcareDrug Manufacturers - Specialty & Generic Website
Price ChartPowered by TradingView
Ask about HLNAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 54 reflects moderate overall profile with moderate momentum, moderate value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.

Momentum
62
Moderate
Value
70
Moderate
Quality
47
Weak
Sentiment
–
no data
Key StatisticsUpdated Apr 15
P/E Ratio
3.65
Forward P/E
–
PEG Ratio
–
EPS (TTM)
2.66
Dividend Yield
1.99%
Beta
0.42
Revenue (TTM)
–
Net Margin
15.11%
ROE
10.30%
Debt / Equity
0.52
52W High
$11.41
52W Low
$8.72
Insider ActivitySEC Form 4 filings
No recent insider buys or sells in the last 90 days.
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
7.51M$75.90MNEW
Point72
Steve Cohen
4.74M$47.92MNEW
Politicians who traded HLNFrom Senate & House PTRs
PoliticianDateTypeAmount
Valerie Hoyle
D-OR
2025-09-23sale$1k – $15k
Lisa McClain
R-MI
2025-06-24purchase$1k – $15k
Valerie Hoyle
D-OR
2024-10-29purchase$1k – $15k
Josh Gottheimer
D-NJ
2024-05-20purchase$1k – $15k
Josh Gottheimer
D-NJ
2023-07-19purchase$1k – $15k
Daniel Goldman
NY
2023-02-27purchase$1k – $15k
About Haleon plc

Haleon Plc - ADR represents an American Depositary Receipt for Haleon Plc, a company known for its focus on consumer healthcare products. ADRs are traded on U.S. stock exchanges and allow American investors to invest in non-U.S. companies without dealing with foreign transactions. Haleon Plc specializes in providing health-related products across various categories, including oral health, pain relief, vitamins, minerals, and supplements, as well as digestive health and other wellness products. The company is a significant player in the global consumer healthcare market, serving regions worldwide. By offering solutions that cater directly to consumer health needs, Haleon's products find utilization in countless households, impacting consumer health and wellness sectors globally. As a spin-off from GlaxoSmithKline (GSK), Haleon continues its legacy of developing solutions aimed at improving everyday health, holding an important role within the healthcare industry due to its broad range of trusted brands and deep industry expertise.

CEO
Mr. Brian James McNamara
Employees
24,561
Quick Facts
Exchange–
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap–
Avg Volume17.92M
Key Dates

Earnings calendar coming soon. Subscribe to get notified when HLN reports next.

Get earnings alerts →